** Shares of drugmaker Viatris rise as much as 9% to a three-month high of $12.65
** Stock set for best day in two years if gains hold
** Viagra maker's Q3 revenue of $3.74 bln beats Wall Street estimates of $3.71 bln, according to data compiled by LSEG
** Q3 adj EPS of 75 cents beats estimates of 68 cents
** YTD, stock up 16.2%
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.